New drug trial offers hope for Tough-to-Treat advanced cancers
Disease control
Recruiting now
This is the first study in people to test a new drug called HMBD-501 for advanced cancers that have a specific marker called HER3 and have stopped responding to standard treatments. The main goals are to find a safe dose and see if the drug can help shrink or control tumors in pa…
Phase: PHASE1, PHASE2 • Sponsor: Hummingbird Bioscience • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC